AIM Vaccine Co Ltd Class H 06660
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- HKD 8.03
- Day Range
- HKD 8.00–8.28
- 52-Week Range
- HKD 6.06–55.40
- Bid/Ask
- HKD 8.03 / HKD 8.04
- Market Cap
- HKD 9.72 Bil
- Volume/Avg
- 320,200 / 527,501
Key Statistics
- Price/Earnings (Normalized)
- 32.63
- Price/Sales
- 7.40
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
AIM Vaccine Co Ltd is a top full-chain vaccine corporation in China with businesses covering the whole industrial chain ranging from research and development to manufacturing and commercialization. The Vaccine products include Recombinant HBV Vaccines, Freeze-dried Human Rabies Vaccine, Inactivated HAV Vaccines, Group A, C, Y, and W135 MPSV, Bivalent Inactivated HFRS Vaccine, and Mumps Vaccine. It generates all of its revenues in the PRC.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- Mid Growth
- Total Number of Employees
- 1,624
- Website
- https://www.aimbio.com
Comparables
Valuation
|
Metric
|
06660
|
300841
|
688670
|
|---|---|---|---|
Price/Earnings (Normalized) | 32.63 | 13.86 | 23.74 |
Price/Book Value | 2.42 | 2.30 | 1.62 |
Price/Sales | 7.40 | 5.12 | 55.27 |
Price/Cash Flow | — | 12.57 | 75.34 |
Price/Earnings
06660
300841
688670
Financial Strength
|
Metric
|
06660
|
300841
|
688670
|
|---|---|---|---|
Quick Ratio | 0.74 | 4.14 | 1.40 |
Current Ratio | 0.95 | 4.49 | 3.34 |
Interest Coverage | −51.05 | 119.95 | −80.32 |
Quick Ratio
06660
300841
688670
Profitability
|
Metric
|
06660
|
300841
|
688670
|
|---|---|---|---|
Return on Assets (Normalized) | −3.57% | — | −4.87% |
Return on Equity (Normalized) | −6.57% | — | −5.91% |
Return on Invested Capital (Normalized) | −4.09% | — | −5.65% |
Return on Assets
06660
300841
688670
Biotechnology Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Zzhwprptf | Fcj | $586.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Xngjknb | Qnycr | $113.7 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Ffvjdvpvg | Tpmdc | $108.2 Bil | |
MRNA
| Moderna Inc | Mlhptdvn | Wgx | $50.9 Bil | |
ARGX
| argenx SE ADR | Pryvktlk | Mkbc | $22.0 Bil | |
BNTX
| BioNTech SE ADR | Ncqjxywfy | Kkh | $21.8 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Ryrdzfbw | Frdwwn | $18.9 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Bxypffrb | Wkdrn | $14.6 Bil | |
INCY
| Incyte Corp | Bgjgvct | Zxzklg | $12.8 Bil | |
RPRX
| Royalty Pharma PLC Class A | Wchqscpcx | Nzblpk | $12.3 Bil |